RUNX1 and acute myeloid leukemia: Meanwhile, mutations in nRAS, RUNX1, FLT3, KIT, etc., abnormalities of DNA methylation, biogenesis of ribosomes, activated signaling pathways, myeloid transcription factors, chromatin remodeling, and cohesion complex processes are very common in AML [15].